Immunogen OverviewImmunogen Operating Income
Operating Income for IMGN.
Quarterly Operating Income
$25.96M
↓ 133.52% YoY
As of Sep 30, 2023
Annual Operating Income (TTM)
$-80185000.00
↓ 59.07% YoY
Trailing 12 months ending Sep 30, 2023
Immunogen OverviewOperating Income for IMGN.
As of Sep 30, 2023
Trailing 12 months ending Sep 30, 2023